This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rohit Kumar Srivastava: Inventor in Therapeutic Gene Editing.
Introduction
Rohit Kumar Srivastava is an inventor associated with Baylor College of Medicine in Houston, Texas. His patent work concerns therapeutic gene editing using gene-targeting antibody fusion proteins.
Latest Patents
Srivastava is associated with one patent: “Utilization of Gene Targeting Antibody Fusion Proteins to Perform In Vivo Therapeutic Gene Editing.” The invention describes an approach that uses antibody fusion proteins to target gene-editing tools in the body. 1 patent is listed for him in the provided information.
Career Highlights
His listed patent connects his work with research into targeted delivery methods for therapeutic gene editing. Baylor College of Medicine is identified as his institutional affiliation.
Collaborations
Clifford Dacso and Sang Jun Han are identified as Srivastava’s coworkers.
Conclusion
Rohit Kumar Srivastava’s listed invention focuses on using gene-targeting antibody fusion proteins for in vivo therapeutic gene editing, reflecting his connection to biomedical research at Baylor College of Medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile